How will PATH work with government and health leaders in Brazil to implement DSJI use if the clinical trials show positive results?
PATH works collaboratively with our global, local, and philanthropic partners to advance the adoption of new technologies. During the course of the project, PATH will work with in-country government and health leaders to communicate the potential benefits (and costs) of the technology, understand the willingness to pay for the DSJI technology, and determine how the DSJI technology can be incorporated into the immunization program in Brazil. A pilot introduction study conducted by PATH should help gather much of this information.
